NO974400L - Combination preparations containing benazepril or benazeprilat and valsartan - Google Patents

Combination preparations containing benazepril or benazeprilat and valsartan

Info

Publication number
NO974400L
NO974400L NO974400A NO974400A NO974400L NO 974400 L NO974400 L NO 974400L NO 974400 A NO974400 A NO 974400A NO 974400 A NO974400 A NO 974400A NO 974400 L NO974400 L NO 974400L
Authority
NO
Norway
Prior art keywords
benazeprilat
valsartan
formula
preparations containing
combination preparations
Prior art date
Application number
NO974400A
Other languages
Norwegian (no)
Other versions
NO974400D0 (en
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO974400D0 publication Critical patent/NO974400D0/en
Publication of NO974400L publication Critical patent/NO974400L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Det er beskrevet f armasizytlske kombinasjonspreparater for behandlingen av hypertensjon, kongestlv hjertefeil og nyresvikt, Innbefattende (1) ACE-lnhibltoren benazeprll av formel (I) eller benazeprilat av formel (II) eller et farmasøytisk akseptabelt salt derav, og (2) ATj^-antagonlsten valsartan av formel (III) eller et farmasizytlsk akseptabelt salt derav, såvel som fremgangsmåter for behandling av hypertensjon, kongestlv hjertefeil og nyresvikt.Pharmaceutical drug combination compositions are disclosed for the treatment of hypertension, congestive heart failure and renal failure, Including (1) the ACE inhibitor benazepril of formula (I) or benazeprilat of formula (II) or a pharmaceutically acceptable salt thereof, and (2) antagonist stone valsartan of formula (III) or a pharmaceutically acceptable salt thereof, as well as methods for the treatment of hypertension, congestive heart failure and renal failure.

NO974400A 1995-04-07 1997-09-23 Combination preparations containing benazepril or benazeprilat and valsartan NO974400L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (2)

Publication Number Publication Date
NO974400D0 NO974400D0 (en) 1997-09-23
NO974400L true NO974400L (en) 1997-09-23

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974400A NO974400L (en) 1995-04-07 1997-09-23 Combination preparations containing benazepril or benazeprilat and valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (en)
JP (1) JPH11503139A (en)
KR (1) KR19980703647A (en)
CN (1) CN1181019A (en)
AU (1) AU5399096A (en)
BR (1) BR9604818A (en)
CA (1) CA2214143A1 (en)
CZ (1) CZ313897A3 (en)
HU (1) HUP9801593A2 (en)
MX (1) MX9707683A (en)
NO (1) NO974400L (en)
PL (1) PL322529A1 (en)
SK (1) SK133897A3 (en)
TR (1) TR199701121T1 (en)
WO (1) WO1996031234A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508894A (en) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Method for treating renal disease using ACE inhibitor and All antagonist
CN101011390A (en) 1999-01-26 2007-08-08 诺瓦提斯公司 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
RU2298418C2 (en) * 2000-04-12 2007-05-10 Новартис Аг Combination of at least two compounds chosen from groups at1-receptor antagonists or inhibitors of ace (angiotensin-converting enzyme) or inhibitors of hmg-coa-reductase (beta-hydroxy-beta-methylglutaryl-coenzyme-a-reductase)
DK1313714T3 (en) 2000-07-19 2008-12-15 Novartis Ag Valsartan salts
JP2004520268A (en) * 2000-08-22 2004-07-08 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Pharmaceutical composition containing an angiotensin II antagonist and an angiotensin I converting enzyme inhibitor
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
WO2002049645A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (en) * 2002-07-05 2008-04-02 安徽省生物医学研究所 Compound medicine for predicting ACEI pressure reducing medicine effect
EP1578360A4 (en) * 2002-08-28 2009-10-21 Curis Inc Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure
EP1908469A1 (en) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (en) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 Antihypertensive medical composite
SG176585A1 (en) 2009-05-20 2012-01-30 Boehringer Ingelheim Vetmed Pharmaceutical oral telmisartan solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN113144204A (en) * 2014-01-31 2021-07-23 詹森药业有限公司 Method for treating and preventing renal and fatty liver diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081564C (en) * 1990-05-11 1998-02-03 Anthony Andrea Fossa Synergistic therapeutic compositions and methods
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
JPH11503139A (en) 1999-03-23
SK133897A3 (en) 1998-02-04
PL322529A1 (en) 1998-02-02
EP0820302A1 (en) 1998-01-28
BR9604818A (en) 1998-06-09
CN1181019A (en) 1998-05-06
NO974400D0 (en) 1997-09-23
WO1996031234A1 (en) 1996-10-10
CZ313897A3 (en) 1998-01-14
TR199701121T1 (en) 1998-03-21
KR19980703647A (en) 1998-12-05
AU5399096A (en) 1996-10-23
CA2214143A1 (en) 1996-10-10
MX9707683A (en) 1997-12-31
HUP9801593A2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
NO974400L (en) Combination preparations containing benazepril or benazeprilat and valsartan
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
MX9707453A (en) Quinazoline derivatives.
GB9914486D0 (en) Medicaments
DK0889877T3 (en) Meta-substituted phenylene derivatives and their use as alpha-beta3 integrin antagonists or inhibitors
DE69831868D1 (en) Antithrombosemittel
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
IL133623A0 (en) Antithrombotic agents
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
ATE195117T1 (en) 1-AMDINOPHENYL-PYRROLIDONE/PIPERIDINONE AS BLOOD ROLLET AGGREGATION INHIBITORS
DK0894084T3 (en) Cinnamic acid derivatives and their use as integrin antagonists
UA49869C2 (en) NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT (VARIANTS), METHOD FOR INHIBITING HUMAN FACTOR Xa OR IIa
MXPA04004674A (en) Cannabinoid receptor ligands.
DK0951474T3 (en) New cyclosporin derivatives, their preparation and pharmaceutical preparations thereof
DE69705829T2 (en) META-SUBSTITUTED PHENYLSULPHONAMIDE DERIVATIVES
DK0958296T3 (en) Heterocyclic Compounds, Methods of Preparation and Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes and Related Diseases
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
AU3664401A (en) Platelet adp receptor inhibitors
ATE235470T1 (en) GASTRIN AND CCK ANTAGONISTS
ATE202337T1 (en) CYCLOPROPYLALKANIC ACID DERIVATIVES
ATE194335T1 (en) 4,5-DIARYLOXAZOLE DERIVATIVES
MX9704856A (en) Substituted indazole derivatives.
NO20001515L (en) Vitronectin receptor antagonist
FI973691A (en) Compositions comprising amlodipine or a salt thereof or felodipine and an ACE inhibitor
NO973652D0 (en) 5- (4-Subst. Piperidinyl-1) -3-aryl pentanoic acid and derivatives as tachykinin receptor antagonist